Monthly Archives: April 2013

Affordable Healthcare Act-pure fiction

I recently dropped off a prescription for my father in law for a branded drug but when I returned to pick it up, the pharmacy had filled it in its generic form instead.  I had the physician contact the pharmacy and the error was corrected, with the pharmacist explaining they “were just gearing up for Obamacare”.   I didn’t dwell on that response, I was just focused on solving the error, however, the pharmacy no longer accepted that insurance and so the “market rate” would apply, a whopping $266.00.

I again had to contact the physician and instructed him to call the prescription into another pharmacy that would honor my father in law’s insurance, total cost: $54.93   He is 86 years young and this is his very first prescription  that he will be required to take daily, and as a formerly healthy man whose only drug was an aspirin a day, he had not enrolled in medicare, as he saw no need to.   Due to his “late enrollment” status, his activation is delayed; fortunately he has health insurance through his former employer.

But as I thought more about the first pharmacist’s response, I became more alarmed.  If my father in law filled this prescription personally, he may not have noted it was not what his doctor prescribed, nor would he have been aware of the side effects of the generic version.  Are pharmacies disregarding all DAW instructions for some segments of the population [elderly] or those that are covered by Medicare? Medicaid?  Was it only the fact that he had private insurance that the DAW was eventually honored?

Careful review of the CBO/Congressional Budget Office report on Affordable Health Care Act, aka Obamacare, includes prescription costs estimated largely on generic drugs.  Further,  more companies are stating, publicly, it is cheaper to pay the fine than insure their employees, when the CBO assumed current levels of insurance coverage by employers.  All of which makes the CBO’s estimates pure fiction.